A17S (p.Ala17Ser) variant of EGFR (Epidermal growth factor receptor)
A17S (p.Ala17Ser) in EGFR (Epidermal growth factor receptor) is a missense change. The available variant effect predictions contribute to a CATVariant prioritization score of 0.16 / 1. The record also includes population frequency data, published literature, and structural context.
A17S (p.Ala17Ser) variant details
- p.Ala17Ser
- gnomAD 7-55019326-G-T
- Missense
- Variant Prioritization Score for Impact Estimate 0.159
- REVEL 0.09
- MetaLR 0.25
- MetaSVM -0.92
- CADD 3.55
- PolyPhen-2 0.01
- SIFT 0.59
- Population evidence available
- Structural context available
- Literature evidence available